InvestorsHub Logo
Followers 98
Posts 9745
Boards Moderated 2
Alias Born 01/01/2006

Re: None

Saturday, 12/05/2020 5:32:01 PM

Saturday, December 05, 2020 5:32:01 PM

Post# of 4107
$SRNE
HERE ARE SORRENTO PIPELINE HIGHLIGHTS WITH RUMORED ACEA AQUSITION...a lot of news coming.

COVID-19 Programs----------------
COVI-TRACE™ Diagnostic Test 45 min.
COVI-TRACK™ Antibody Test 8 min.
COVI-STIX 15 min.
COVI-GUARD™ Neutralizing Antibody
COVI-AMG™ Neutralizing Antibody 2020
plasmid DNA 2020
COVI-DROPS nasal 2020
aMSC cell therapy phase 1
ABIVERTINIB Cytokine Storm phase 2
Celularity phase 1/2 (25% interest)

CANCER Immunotherapy-------------
CD38 CAR-T Multiple Myeloma
CD38 DAR-T Multiple Myeloma
CD38 ADC Amyloidosis
Seprehvir™ Solid Tumors
ABIVERTINIB NSCLC phase 3
ABIVIRTINIB lymphomas phase 2
ADNIC Solid and Liquid Tumors phase 2

NON-OPIOID Pain--------------
RTX (resiniferatoxin)Epidural route Terminal Cancer Pain Orphan status
RTX (resiniferatoxin) Intra-articular route Moderate to Severe OA
RTX (resiniferatoxin)TKR deferment
SP-102 lumbar/sciatic pain pivotal phase 3 results 2021

ACEA Therapeutics portfolio

Oncology--------------
Abivertinib EGFR T790M+(2nd Line)phase 3 NDA approval China
EGFR mut+(1st Line) Lymphomas China phase 2
AC0002 CNS Tumors Global
AC0078 Pan-TRK inhibitor Global
ACT01 Multiple oncology indications Global
ACT02 Multiple oncology indications Global
ACT03 Multiple oncology indications Global
ACT04 Multiple oncology indications Global

Autoimmune Disease------------
AC0058 phase 2


A goal is a dreams deadline...what is your goal?

´¯`·.¸¸.·´¯`·.¸ ><((((((º>
`·.¸¸.·´¯`·.¸¸.·´¯`·.¸ ><((((º>

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.